80 related articles for article (PubMed ID: 24983457)
1. The human-specific invariant chain isoform Iip35 modulates Iip33 trafficking and function.
Sand KM; Landsverk OJ; Berg-Larsen A; Bakke O; Gregers TF
Immunol Cell Biol; 2014 Oct; 92(9):791-8. PubMed ID: 24983457
[TBL] [Abstract][Full Text] [Related]
2. Exit of major histocompatibility complex class II-invariant chain p35 complexes from the endoplasmic reticulum is modulated by phosphorylation.
Kuwana T; Peterson PA; Karlsson L
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1056-61. PubMed ID: 9448284
[TBL] [Abstract][Full Text] [Related]
3. A three-amino-acid-long HLA-DRbeta cytoplasmic tail is sufficient to overcome ER retention of invariant-chain p35.
Khalil H; Brunet A; Thibodeau J
J Cell Sci; 2005 Oct; 118(Pt 20):4679-87. PubMed ID: 16188937
[TBL] [Abstract][Full Text] [Related]
4. Human invariant chain isoform p35 restores thymic selection and antigen presentation in CD74-deficient mice.
Genève L; Chemali M; Desjardins M; Labrecque N; Thibodeau J
Immunol Cell Biol; 2012 Oct; 90(9):896-902. PubMed ID: 22689013
[TBL] [Abstract][Full Text] [Related]
5. The p35 human invariant chain in transgenic mice restores mature B cells in the absence of endogenous CD74.
Genève L; Ménard C; Labrecque N; Thibodeau J
Int Immunol; 2012 Oct; 24(10):645-60. PubMed ID: 22966065
[TBL] [Abstract][Full Text] [Related]
6. The MHC class II beta chain cytoplasmic tail overcomes the invariant chain p35-encoded endoplasmic reticulum retention signal.
Khalil H; Brunet A; Saba I; Terra R; Sékaly RP; Thibodeau J
Int Immunol; 2003 Oct; 15(10):1249-63. PubMed ID: 13679394
[TBL] [Abstract][Full Text] [Related]
7. ER egress of invariant chain isoform p35 requires direct binding to MHCII molecules and is inhibited by the NleA virulence factor of enterohaemorrhagic Escherichia coli.
Cloutier M; Gauthier C; Fortin JS; Genève L; Kim K; Gruenheid S; Kim J; Thibodeau J
Hum Immunol; 2015 Apr; 76(4):292-6. PubMed ID: 25731712
[TBL] [Abstract][Full Text] [Related]
8. The invariant chain p35 isoform promotes formation of nonameric complexes with MHC II molecules.
Cloutier M; Gauthier C; Fortin JS; Thibodeau J
Immunol Cell Biol; 2014 Jul; 92(6):553-6. PubMed ID: 24638068
[TBL] [Abstract][Full Text] [Related]
9. Transport properties of free and MHC class II-associated oligomers containing different isoforms of human invariant chain.
Arunachalam B; Lamb CA; Cresswell P
Int Immunol; 1994 Mar; 6(3):439-51. PubMed ID: 8186195
[TBL] [Abstract][Full Text] [Related]
10. MHC II and the endocytic pathway: regulation by invariant chain.
Landsverk OJ; Bakke O; Gregers TF
Scand J Immunol; 2009 Sep; 70(3):184-93. PubMed ID: 19703008
[TBL] [Abstract][Full Text] [Related]
11. Invariant chain increases the half-life of MHC II by delaying endosomal maturation.
Landsverk OJ; Barois N; Gregers TF; Bakke O
Immunol Cell Biol; 2011 Jul; 89(5):619-29. PubMed ID: 21116285
[TBL] [Abstract][Full Text] [Related]
12. The cytoplasmic tail of invariant chain modulates antigen processing and presentation.
Gregers TF; Nordeng TW; Birkeland HC; Sandlie I; Bakke O
Eur J Immunol; 2003 Feb; 33(2):277-86. PubMed ID: 12548558
[TBL] [Abstract][Full Text] [Related]
13. An N-terminal double-arginine motif maintains type II membrane proteins in the endoplasmic reticulum.
Schutze MP; Peterson PA; Jackson MR
EMBO J; 1994 Apr; 13(7):1696-705. PubMed ID: 8157008
[TBL] [Abstract][Full Text] [Related]
14. In vivo control of endosomal architecture by class II-associated invariant chain and cathepsin S.
Boes M; van der Wel N; Peperzak V; Kim YM; Peters PJ; Ploegh H
Eur J Immunol; 2005 Sep; 35(9):2552-62. PubMed ID: 16094690
[TBL] [Abstract][Full Text] [Related]
15. Mutation of the invariant chain transmembrane region inhibits II degradation, prolongs association with MHC class II, and selectively disrupts antigen presentation.
Frauwirth K; Shastri N
Cell Immunol; 2001 May; 209(2):97-108. PubMed ID: 11446742
[TBL] [Abstract][Full Text] [Related]
16. The invariant chain transports TNF family member CD70 to MHC class II compartments in dendritic cells.
Zwart W; Peperzak V; de Vries E; Keller AM; van der Horst G; Veraar EA; Geumann U; Janssen H; Janssen L; Naik SH; Neefjes J; Borst J
J Cell Sci; 2010 Nov; 123(Pt 21):3817-27. PubMed ID: 20971706
[TBL] [Abstract][Full Text] [Related]
17. Invariant chain is a new chaperone for TLR7 in B cells.
Tohmé M; Manoury B
Mol Immunol; 2015 Dec; 68(2 Pt A):102-5. PubMed ID: 26198699
[TBL] [Abstract][Full Text] [Related]
18. The Influence of MHC Class II on B Cell Defects Induced by Invariant Chain/CD74 N-Terminal Fragments.
Schneppenheim J; Loock AC; Hüttl S; Schweizer M; Lüllmann-Rauch R; Oberg HH; Arnold P; Lehmann CHK; Dudziak D; Kabelitz D; Lucius R; Lennon-Duménil AM; Saftig P; Schröder B
J Immunol; 2017 Jul; 199(1):172-185. PubMed ID: 28550201
[TBL] [Abstract][Full Text] [Related]
19. Invariant chain-MHC class II complexes: always odd and never invariant.
Cresswell P; Roche PA
Immunol Cell Biol; 2014 Jul; 92(6):471-2. PubMed ID: 24777311
[No Abstract] [Full Text] [Related]
20. Intracellular transport of MHC class II and associated invariant chain in antigen presenting cells from AP-3-deficient mocha mice.
Sevilla LM; Richter SS; Miller J
Cell Immunol; 2001 Jun; 210(2):143-53. PubMed ID: 11520080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
